Stock comparison

GILDvsINSM

Gilead Sciences IncvsInsmed Inc. Real data pulled from the alphactor.ai fundamentals pipeline — valuation, balance-sheet health, momentum, and analyst sentiment side by side.

GILD

Gilead Sciences Inc

$133.64

+10.12%

Biotechnology$173.4BNASDAQ

INSM

Insmed Inc

$144.48

-26.63%

Biotechnology$35.0BNASDAQ

60-day price, rebased to 100

GILD -6.47% · INSM -8.45%

Round-by-round

GILD 5·INSM 1

EdgeGILD

Valuation upside

-27.50% vs -90.50% to DCF fair value

EdgeINSM

Balance-sheet strength

Altman Z 4.47 vs 9.81

EdgeGILD

Fundamental quality

Piotroski 8.00 vs 4.00 (of 9)

EdgeGILD

Growth + margins

Rule-of-40 34.50 vs -92.80

EdgeGILD

60-day momentum

-6.47% vs -8.45% price return

EdgeGILD

Market-cap liquidity

$173.4B vs $35.0B

Verdict

Across6categories,GILDtakes the edge with5wins to1. Neither score is a buy signal on its own: run the full backtest and credibility tests on alphactor.ai before putting money on it.

Backtest a strategy onGILDorINSM

Point-in-time backtests, 8-layer credibility pipeline, conviction scoring — free to start.